These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1837764)

  • 1. [Oral administration of extracted kallikrein to patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Ferri C; Luparini RL; Germanò G; Giarrizzo C; Santucci A; Balsano F
    Clin Ter; 1991 Oct 15-31; 139(1-2):3-8. PubMed ID: 1837764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy and tolerance of orally administered kallikrein in patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Torregrossa G; Leonetti Luparini R; Germanò G; Giarrizzo C; Ferri C; Santucci A
    Ann Ital Med Int; 1991; 6(4):369-74. PubMed ID: 1804283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
    Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of oral kallikrein in lowering systemic blood pressure in primary hypertension.
    Bönner G; Toussaint C; Claus M; Fritschka E; Philipp T; Vetter H; Feltkamp H
    Agents Actions Suppl; 1992; 38 ( Pt 3)():294-303. PubMed ID: 1462864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives.
    Valdés G; Vio CP; Montero J; Avendaño R
    J Hum Hypertens; 1991 Apr; 5(2):91-6. PubMed ID: 2072372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.
    Bellini C; Ferri C; Piccoli A; Carlomagno A; Di Francesco L; Bonavita MS; Santucci A; Balsano F
    Nephron; 1993; 65(1):28-35. PubMed ID: 8413787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
    Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
    Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary kallikrein activity is increased during the first few weeks of exercise training in essential hypertension.
    Miura S; Tashiro E; Sakai T; Koga M; Kinoshita A; Sasaguri M; Ideishi M; Ikeda M; Tanaka H; Shindo M
    J Hypertens; 1994 Jul; 12(7):815-23. PubMed ID: 7963511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein excretion is low in malignant essential hypertension.
    Hilme E; Herlitz H; Gyzander E; Hansson L
    J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
    J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Stumpe KO; Overlack A; Ressel C; Krück F
    Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation of atrial natriuretic peptide, the renin-angiotensin-aldosterone system and kinin system in hypertensive and normotensive youngsters with or without a family history of essential arterial hypertension].
    Musca A; Ferri C; Cammerella I; Onofri R; Tani S; Santucci A
    Medicina (Firenze); 1989; 9(2):167-72. PubMed ID: 2530412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system.
    Yasujima M; Abe K; Tanno M; Kasai Y; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Hypertension; 1984; 6(2 Pt 1):229-35. PubMed ID: 6327517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
    Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
    Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and antihypertensive effects of felodipine in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Cuspidi C; Sampieri L; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S161-3. PubMed ID: 2856695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.
    Horwitz D; Margolius HS; Keiser HR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.